Table 1.
Self‐reported characteristics of 21 participants
| Age (mean = 34.8 yrs) | n | % | Occupation | n | % |
| 25–29 | 3 | 14 | Artist/creative | 1 | 3 |
| 30–34 | 6 | 28 | Caregiver | 1 | 3 |
| 35–39 | 8 | 38 | Communications | 1 | 3 |
| 40–44 | 2 | 10 | Government/policy/administration | 3 | 10 |
| 45+ | 1 | 5 | Lawyer/legal advisor | 2 | 6 |
| DNA* | 1 | 5 | Recreation/social services | 2 | 6 |
| Employment status | n | % | Retail/business/finance | 4 | 13 |
| Working at time of interview | 13 | 62 | Teacher/librarian | 4 | 13 |
| Not working at time of interview | 7 | 33 | DNA | 3 | 10 |
| DNA | 1 | 5 | Marital status | n | % |
| Age at onset (of first diagnosis) | n | % | Married | 10 | 48 |
| 15–19 | 3 | 14 | Common law | 10 | 48 |
| 20–24 | 2 | 10 | DNA | 1 | 5 |
| 25–29 | 4 | 19 | Number of other children | n | % |
| 30–34 | 9 | 43 | 1 | 14 | 67 |
| 35–39 | 1 | 5 | 2 | 6 | 28 |
| DNA* | 2 | 10 | 3 | 0 | 0 |
| Self‐reported symptoms** | n | % | 4 | 1 | 5 |
| Anxiety symptoms | 17 | 45 | Treatment(s) & medication(s) used** | n | % |
| Agoraphobia | 1 | Cognitive behavioural therapy | 1 | 3 | |
| Anguish | 2 | Anti‐depressants (SSRIs and SNRIs) | 20 | 65 | |
| Anxiety | 10 | Anti‐psychotics | 4 | 13 | |
| Social phobia | 1 | Mood stabilizers | 2 | 6 | |
| Post‐traumatic stress disorder | 3 | Benzodiazapines | 1 | 3 | |
| Mood symptoms | 13 | 34 | None | 3 | 10 |
| Depression | 6 | Mother tongue | n | % | |
| Postpartum depression | 6 | English | 10 | 48 | |
| Bipolar | 1 | French | 7 | 33 | |
| Psychotic symptoms | 2 | 5 | Bulgarian | 1 | 5 |
| Paranoia | 1 | Armenian | 1 | 5 | |
| Psychosis | 1 | DNA | 2 | 10 | |
| Personality symptoms | 1 | 3 | Country of birth | n | % |
| Borderline personality | 1 | Canada | 17 | 81 | |
| Developmental problems | 1 | 3 | Bulgaria | 1 | 5 |
| Attention deficit/hyperactivity disorder | 1 | Saudi Arabia | 1 | 5 | |
| DNA | 4 | 11 | DNA* | 2 | 10 |
| Ethnic background | n | % | |||
| Caucasian | 5 | 24 | |||
| Armenian | 1 | 5 | |||
| Canadian | 1 | 5 | |||
| White | 1 | 5 | |||
| North American | 1 | 5 | |||
| DNA | 12 | 57 |
*
DNA = did not answer.
**
Participants may have reported more than 1 symptom, treatment and/or medication. NB ‐ total % in the columns is not always equal to exactly 100% given rounding errors.